Although wholesalers are confirming that GLP-1 therapies are back in stock, many pharmacies have still not received stock or are simply unable to maintain adequate stock levels due to the uncertainty of the supply chain
What we do know is that many people regain weight quickly after stopping them, which suggests this may become a lifelong medication for many users, Kevin Thompson, the CEO of 9i Capital Group and the host of the 9innings podcast, told Newsweek
Hepatic or renal impairment these are compounds handled by the liver and kidneys
However, the UK National Autistic Society says around a third of autistic people also have a learning disability, and rates of mental health problems are higher
Smits RM, Mackenzie-Proctor R, Fleischer K, Showell MG
When retatrutide becomes available, switching protocols from Mounjaro to retatrutide will follow similar principles, and data on switching from tirzepatide to retatrutide is already being generated in clinical trials